Skip to main navigation Skip to search Skip to main content

Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: A prospective follow-up study

  • Hwan Kim Jeong
  • , Hyoek Lee Joon
  • , Jong Park Sang
  • , Hee Bae Mun
  • , Hyang Kim Ji
  • , Young Kim Do
  • , Kyu Kim Jong
  • , Seok Choi Moon
  • , Cheol Koh Kwang
  • , Woon Paik Seung
  • , Chul Yoo Byung
  • Konkuk University
  • Sungkyunkwan University

Research output: Contribution to journalArticlepeer-review

Abstract

Background/Aims: Although the natural seroclearance rate of Hepatitis B surface antigen (HBsAg) is reported to be 0.4-2% in western countries, this is not well known in Korea. This study aimed to elucidate the rate of natural HbsAg seroclearance, factors associated with seroclearance and prognosis after seroclearance. Methodology: In 1999, 250 chronic HBsAg carriers without any history of antiviral treatment and without any evidence of liver cirrhosis or hepatocellular carcinoma were selected. Follow-up HBsAg/anti-HBs tests were performed annually till 2004. During a mean follow-up period of 48 months, 24 patients were lost and 11 received antiviral treatment. Finally, 215 patients completed the study. Results: HBsAg seroclearance was observed in 11 patients (6 males, 5 females). One-year seroclearance rate was 1.4%. All patients who achieved seroclearance were HBeAg (-)/HBV DNA (-) at the time of enrollment. Additionally, old age and normal serum alanine aminotransferase (ALT) level were the factors associated with seroclearance (p<0.05, respectively). During the follow-up period, only mild transient elevations of ALT were observed in 4 patients and no serious complications were observed. Conclusions: Natural seroclearance occurred exclusively in patients who were HBeAg (-)/HBV-DNA (-), and annual rate of natural HBsAg seroclearance was 1.4%. No significant complications were observed after seroclearance.

Original languageEnglish
Pages (from-to)578-581
Number of pages4
JournalHepato-Gastroenterology
Volume55
Issue number82-83
StatePublished - Mar 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Hepatitis B surface antigen
  • Hepatitis B virus
  • Prognosis
  • Seroclearance

Fingerprint

Dive into the research topics of 'Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: A prospective follow-up study'. Together they form a unique fingerprint.

Cite this